$8 and beyond, page-41

Have to say the slide to -7 is looking like accumulation time
There should be a news flow soon not just with the extra European countries coming on line but
1 csiro update / production and generic products
2 us Pharamacy sales
3 clinical trials in Europe amongst children
4 repeat sales in existing countries
5 progress with us approvals

I have spent most of what I have on mvp and cla both looking good

MVP in my view is what I buy when ever I have a win elsewhere, never sold one.

Don’t understand why we are not north of $7.50 though.